X-133336655-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001448.3(GPC4):​c.319+2528T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.371 in 109,947 control chromosomes in the GnomAD database, including 6,447 homozygotes. There are 11,388 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 6447 hom., 11388 hem., cov: 21)

Consequence

GPC4
NM_001448.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.336

Publications

1 publications found
Variant links:
Genes affected
GPC4 (HGNC:4452): (glypican 4) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The GPC4 gene is adjacent to the 3' end of GPC3 and may also play a role in Simpson-Golabi-Behmel syndrome. [provided by RefSeq, Jul 2008]
GPC4 Gene-Disease associations (from GenCC):
  • Keipert syndrome
    Inheritance: XL, XLR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001448.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.589 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001448.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC4
NM_001448.3
MANE Select
c.319+2528T>C
intron
N/ANP_001439.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC4
ENST00000370828.4
TSL:1 MANE Select
c.319+2528T>C
intron
N/AENSP00000359864.3O75487-1
GPC4
ENST00000887818.1
c.319+2528T>C
intron
N/AENSP00000557877.1
GPC4
ENST00000931828.1
c.319+2528T>C
intron
N/AENSP00000601887.1

Frequencies

GnomAD3 genomes
AF:
0.371
AC:
40746
AN:
109894
Hom.:
6443
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.597
Gnomad AMI
AF:
0.401
Gnomad AMR
AF:
0.234
Gnomad ASJ
AF:
0.319
Gnomad EAS
AF:
0.432
Gnomad SAS
AF:
0.491
Gnomad FIN
AF:
0.219
Gnomad MID
AF:
0.308
Gnomad NFE
AF:
0.279
Gnomad OTH
AF:
0.351
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.371
AC:
40770
AN:
109947
Hom.:
6447
Cov.:
21
AF XY:
0.353
AC XY:
11388
AN XY:
32253
show subpopulations
African (AFR)
AF:
0.597
AC:
17929
AN:
30043
American (AMR)
AF:
0.234
AC:
2432
AN:
10394
Ashkenazi Jewish (ASJ)
AF:
0.319
AC:
838
AN:
2627
East Asian (EAS)
AF:
0.432
AC:
1487
AN:
3441
South Asian (SAS)
AF:
0.493
AC:
1239
AN:
2512
European-Finnish (FIN)
AF:
0.219
AC:
1274
AN:
5813
Middle Eastern (MID)
AF:
0.304
AC:
65
AN:
214
European-Non Finnish (NFE)
AF:
0.279
AC:
14711
AN:
52731
Other (OTH)
AF:
0.350
AC:
524
AN:
1497
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
843
1686
2529
3372
4215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.310
Hom.:
3481
Bravo
AF:
0.381

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.2
DANN
Benign
0.75
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41537046;
hg19: chrX-132470683;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.